151 related articles for article (PubMed ID: 1919609)
1. The thymus in seronegative myasthenia gravis patients.
Willcox N; Schluep M; Ritter MA; Newsom-Davis J
J Neurol; 1991 Aug; 238(5):256-61. PubMed ID: 1919609
[TBL] [Abstract][Full Text] [Related]
2. Variable corticosteroid sensitivity of thymic cortex and medullary peripheral-type lymphoid tissue in myasthenia gravis patients: structural and functional effects.
Willcox N; Schluep M; Sommer N; Campana D; Janossy G; Brown AN; Newsom-Davis J
Q J Med; 1989 Nov; 73(271):1071-87. PubMed ID: 2623139
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis.
Zisimopoulou P; Evangelakou P; Tzartos J; Lazaridis K; Zouvelou V; Mantegazza R; Antozzi C; Andreetta F; Evoli A; Deymeer F; Saruhan-Direskeneli G; Durmus H; Brenner T; Vaknin A; Berrih-Aknin S; Frenkian Cuvelier M; Stojkovic T; DeBaets M; Losen M; Martinez-Martinez P; Kleopa KA; Zamba-Papanicolaou E; Kyriakides T; Kostera-Pruszczyk A; Szczudlik P; Szyluk B; Lavrnic D; Basta I; Peric S; Tallaksen C; Maniaol A; Tzartos SJ
J Autoimmun; 2014 Aug; 52():139-45. PubMed ID: 24373505
[TBL] [Abstract][Full Text] [Related]
4. The immunologic role of thymectomy in the treatment of myasthenia gravis: implication of thymus-associated B-lymphocyte subset in reduction of the anti-acetylcholine receptor antibody titer.
Okumura M; Ohta M; Takeuchi Y; Shiono H; Inoue M; Fukuhara K; Kadota Y; Miyoshi S; Fujii Y; Matsuda H
J Thorac Cardiovasc Surg; 2003 Dec; 126(6):1922-8. PubMed ID: 14688707
[TBL] [Abstract][Full Text] [Related]
5. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
[TBL] [Abstract][Full Text] [Related]
6. Selective impairment of serum antibody repertoires toward muscle and thymus antigens in patients with seronegative and seropositive myasthenia gravis.
Sharshar T; Lacroix-Desmazes S; Mouthon L; Kaveri S; Gajdos P; Kazatchkine MD
Eur J Immunol; 1998 Aug; 28(8):2344-54. PubMed ID: 9710212
[TBL] [Abstract][Full Text] [Related]
7. Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis.
Fujii Y; Hashimoto J; Monden Y; Ito T; Nakahara K; Kawashima Y
J Immunol; 1986 Feb; 136(3):887-91. PubMed ID: 2416838
[TBL] [Abstract][Full Text] [Related]
8. Myasthenia gravis thymus: clinical, histological and culture correlations.
Schluep M; Willcox N; Ritter MA; Newsom-Davis J; Larché M; Brown AN
J Autoimmun; 1988 Oct; 1(5):445-67. PubMed ID: 3254184
[TBL] [Abstract][Full Text] [Related]
9. Immunohistological studies of the thymus in myasthenia gravis. Correlation with clinical state and thymocyte culture responses.
Thomas JA; Willcox HN; Newsom-Davis J
J Neuroimmunol; 1982 Dec; 3(4):319-35. PubMed ID: 6757263
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y
J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to thymic epithelial cells in myasthenia gravis.
Safar D; Aimé C; Cohen-Kaminsky S; Berrih-Aknin S
J Neuroimmunol; 1991 Dec; 35(1-3):101-10. PubMed ID: 1720131
[TBL] [Abstract][Full Text] [Related]
12. Thymocyte Fas expression is dysregulated in myasthenia gravis patients with anti-acetylcholine receptor antibody.
Moulian N; Bidault J; Truffault F; Yamamoto AM; Levasseur P; Berrih-Aknin S
Blood; 1997 May; 89(9):3287-95. PubMed ID: 9129034
[TBL] [Abstract][Full Text] [Related]
13. Greatly increased autoantibody production in myasthenia gravis by thymocyte suspensions prepared with proteolytic enzymes.
Willcox HN; Newsom-Davis J; Calder LR
Clin Exp Immunol; 1983 Nov; 54(2):378-86. PubMed ID: 6317238
[TBL] [Abstract][Full Text] [Related]
14. Anti-AChR antibodies, thymic histology, and T cell subsets in myasthenia gravis.
Berrih S; Morel E; Gaud C; Raimond F; Le Brigand H; Bach JF
Neurology; 1984 Jan; 34(1):66-71. PubMed ID: 6228745
[TBL] [Abstract][Full Text] [Related]
15. The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat.
Meinl E; Klinkert WE; Wekerle H
Am J Pathol; 1991 Nov; 139(5):995-1008. PubMed ID: 1951638
[TBL] [Abstract][Full Text] [Related]
16. Antibody-secreting cells to acetylcholine receptor and to presynaptic membrane receptor in seronegative myasthenia gravis.
Lu CZ; Lu L; Hao ZS; Xia DG; Qain J; Arnason BG
J Neuroimmunol; 1993 Mar; 43(1-2):145-9. PubMed ID: 8384634
[TBL] [Abstract][Full Text] [Related]
17. Antibody to acetylcholine receptor in myasthenia gravis: production by lymphocytes from thymus or thymoma.
Fujii Y; Monden Y; Nakahara K; Hashimoto J; Kawashima Y
Neurology; 1984 Sep; 34(9):1182-6. PubMed ID: 6611521
[TBL] [Abstract][Full Text] [Related]
18. Thymus cells in myasthenia gravis: a two-colour flow cytometric analysis of lymphocytes in the thymus and thymoma.
Fujii Y; Hayakawa M; Nakahara K
J Neurol; 1992 Feb; 239(2):82-8. PubMed ID: 1552308
[TBL] [Abstract][Full Text] [Related]
19. Acetylcholine receptor autoantibody secretion by thymocytes: relationship to myasthenia gravis.
Yoshikawa H; Lennon VA
Neurology; 1997 Aug; 49(2):562-7. PubMed ID: 9270597
[TBL] [Abstract][Full Text] [Related]
20. Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor.
Vrolix K; Fraussen J; Losen M; Stevens J; Lazaridis K; Molenaar PC; Somers V; Bracho MA; Le Panse R; Stinissen P; Berrih-Aknin S; Maessen JG; Van Garsse L; Buurman WA; Tzartos SJ; De Baets MH; Martinez-Martinez P
J Autoimmun; 2014 Aug; 52():101-12. PubMed ID: 24439114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
